Endo Health Solutions (ENDP) announced after the bell Wednesday that it is exploring strategic alternatives for its HealthTronics business and branded pharmaceutical discovery platform. The company expects to report full year 2013 adjusted EPS of $4.10 to $4.40. The consensus estimate is for EPS of $4.27. The stock is now up 0.81 on 88K shares.
Endo Health Solutions dipped in early trade Wednesday, but settled into a range for the majority of the session. Shares finished down by 0.50 at $35.96.
For comments and feedback: editorial@rttnews.com